![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jan ter Meulen. (2007) Monoclonal antibodies for prophylaxis and therapy of infectious diseases. Expert Opinion on Emerging Drugs 12:4, pages 525-540.
Read now
Read now
Articles from other publishers (36)
Rui Xiong, Rui Fu, Yong Wu, Xi Wu, Yuan Cao, Zhe Qu, Yanwei Yang, Susu Liu, Guitao Huo, Sanlong Wang, Weijin Huang, Jianjun Lyu, Xiang Zhu, Chunnan Liang, Yihong Peng, Youchun Wang & Changfa Fan. (2022) Long-Term Infection and Pathogenesis in a Novel Mouse Model of Human Respiratory Syncytial Virus. Viruses 14:8, pages 1740.
Crossref
Crossref
Olivia E. Harder & Stefan Niewiesk. (2022) Respiratory Syncytial Virus Infection Modeled in Aging Cotton Rats (Sigmodon hispidus) and Mice (Mus musculus). Advances in Virology 2022, pages 1-6.
Crossref
Crossref
Pragya D. Yadav, Sanjeev Kumar Mendiratta, Sreelekshmy Mohandas, Arun K. Singh, Priya Abraham, Anita Shete, Sanjay Bandyopadhyay, Sanjay Kumar, Aashini Parikh, Pankaj Kalita, Vibhuti Sharma, Hardik Pandya, Chirag G. Patel, Mihir Patel, Swagat Soni, Suresh Giri & Mukul Jain. (2021) ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection. Viruses 13:12, pages 2424.
Crossref
Crossref
Olivia E. Harder, Margaret Martinez & Stefan Niewiesk. (2021) Nonsteroidal anti-inflammatory drugs restore immune function to respiratory syncytial virus in geriatric cotton rats (Sigmodon hispidus). Virology 563, pages 28-37.
Crossref
Crossref
Sol Ferrero, Maria D. Flores, Connor Short, Cecilia A. Vazquez, Lars E. Clark, James Ziegenbein, Samantha Zink, Daniel Fuentes, Cristian Payes, María V. Batto, Michael Collazo, Cybele C. García, Jonathan Abraham, Sandra M. Cordo, Jose A. Rodriguez & Gustavo Helguera. (2021) Antibody-Based Inhibition of Pathogenic New World Hemorrhagic Fever Mammarenaviruses by Steric Occlusion of the Human Transferrin Receptor 1 Apical Domain. Journal of Virology 95:17.
Crossref
Crossref
Dharma Rao Tompa, Aruldoss Immanuel, Srimari Srikanth & Saraboji Kadhirvel. (2021) Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs. International Journal of Biological Macromolecules 172, pages 524-541.
Crossref
Crossref
Young-Man Kwon, Youri Lee, Ki Hye Kim, Yu Jin Jung, Zhuo Li, Subbiah Jeeva, Sujin Lee, Martin L. Moore & Sang-Moo Kang. (2019) Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles. Vaccine 37:44, pages 6656-6664.
Crossref
Crossref
Jonatan J. Carvajal, Andrea M. Avellaneda, Camila Salazar-Ardiles, Jorge E. Maya, Alexis M. Kalergis & Margarita K. Lay. (2019) Host Components Contributing to Respiratory Syncytial Virus Pathogenesis. Frontiers in Immunology 10.
Crossref
Crossref
Sandra Piras, Giuseppina Sanna, Antonio Carta, Paola Corona, Roberta Ibba, Roberta Loddo, Silvia Madeddu, Paola Caria, Suzana Aulic, Erik Laurini, Maurizio Fermeglia & Sabrina Pricl. (2019) Dichloro-Phenyl-Benzotriazoles: A New Selective Class of Human Respiratory Syncytial Virus Entry Inhibitors. Frontiers in Chemistry 7.
Crossref
Crossref
Roberta Crim, Sangeeta Kumari, Priyanka Jayanti, Susette Audet, Ashwin Kulkarni & Judy Beeler. (2019) Development of Luciferase Immunoprecipitation Systems (LIPS) Assay to Detect IgG Antibodies against Human Respiratory Syncytial Virus G-Glycoprotein. Vaccines 7:1, pages 16.
Crossref
Crossref
Sung Hui Chang, Gwang Cheon Jang & Shin Won Yoon. (2018) Clinical Features of Respiratory Syncytial Virus Infection in Neonates: A Single Center Study. Neonatal Medicine 25:4, pages 144-152.
Crossref
Crossref
Kok Fei Chan, Louise A. Carolan, Julian Druce, Keith Chappell, Daniel Watterson, Paul Young, Daniil Korenkov, Kanta Subbarao, Ian G. Barr, Karen L. Laurie & Patrick C. Reading. (2018) Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection. Journal of Virology 92:4.
Crossref
Crossref
Ying Hua, Yue-Ying Jiao, Yao Ma, Xiang-Lei Peng, Yuan-Hui Fu, Xiu-Juan Zhang, Yuan-Bo Zheng, Yan-Peng Zheng, Tao Hong & Jin-Sheng He. (2017) Enhanced humoral and CD8 + T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells. International Immunopharmacology 46, pages 62-69.
Crossref
Crossref
Geraldine Taylor. (2017) Animal models of respiratory syncytial virus infection. Vaccine 35:3, pages 469-480.
Crossref
Crossref
Lori McGinnes Cullen, Madelyn R. Schmidt, Sarah A. Kenward, Robert T. Woodland & Trudy G. Morrison. (2015) Murine Immune Responses to Virus-Like Particle-Associated Pre- and Postfusion Forms of the Respiratory Syncytial Virus F Protein. Journal of Virology 89:13, pages 6835-6847.
Crossref
Crossref
Marian Wiegand & Wolfgang J. Neubert. 2013. Sendai Virus Vector. Sendai Virus Vector
91
126
.
Trudy G. Morrison & Edward E. Walsh. 2013. Challenges and Opportunities for Respiratory Syncytial Virus Vaccines. Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
285
306
.
Kyu Hee ParkJeong Hee ShinEun Hee LeeWon Hui SeoYun Kyung KimDae Jin SongByung Min ChoiJi Tae ChoungYoung Sook Hong. (2012) Seasonal Variations of Respiratory Syncytial Virus Infection among the Children under 60 Months of Age with Lower Respiratory Tract Infections in the Capital Area, the Republic of Korea, 2008-2011. Journal of the Korean Society of Neonatology 19:4, pages 195.
Crossref
Crossref
Shayne Cox GadGuo-Liang Yu & Jian Ni. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Rajni Kumaria, Laxmi Ravi Iyer, Martin L Hibberd, Eric AF Simões & Richard J Sugrue. (2011) Whole genome characterization of non-tissue culture adapted HRSV strains in severely infected children. Virology Journal 8:1.
Crossref
Crossref
Melvin Wright & Giovanni Piedimonte. (2010) Respiratory syncytial virus prevention and therapy: Past, present, and future. Pediatric Pulmonology 46:4, pages 324-347.
Crossref
Crossref
Lori W. McGinnes, Kathryn A. Gravel, Robert W. Finberg, Evelyn A. Kurt-Jones, Michael J. Massare, Gale Smith, Madelyn R. Schmidt & Trudy G. Morrison. (2011) Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins. Journal of Virology 85:1, pages 366-377.
Crossref
Crossref
Michael N. Teng. 2011. Replicating Vaccines. Replicating Vaccines
237
259
.
E.A. Dizdar, C. Aydemir, O. Erdeve, F.N. Sari, S. Oguz, N. Uras & U. Dilmen. (2010) Respiratory syncytial virus outbreak defined by rapid screening in a neonatal intensive care unit. Journal of Hospital Infection 75:4, pages 292-294.
Crossref
Crossref
Alla Musiyenko, Lucia Correa, Nicholas Stock, John H. Hutchinson, Daniel S. Lorrain, Gretchen Bain, Jilly F. Evans & Sailen Barik. (2009) A Novel 5-Lipoxygenase-Activating Protein Inhibitor, AM679, Reduces Inflammation in the Respiratory Syncytial Virus-Infected Mouse Eye. Clinical and Vaccine Immunology 16:11, pages 1654-1659.
Crossref
Crossref
Teresa R. Johnson, Srinivas Rao, Robert A. Seder, Man Chen & Barney S. Graham. (2009) TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity. Vaccine 27:23, pages 3045-3052.
Crossref
Crossref
Caroline Breese Hall & Edward E. Walsh. 2009. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Feigin and Cherry's Textbook of Pediatric Infectious Diseases
2462
2487
.
Olaf Weber. 2009. Commond Cold. Commond Cold
107
147
.
SIMON P. HOGAN, HELENE F. ROSENBERG, REDWAN MOQBEL, SIMON PHIPPS, PAUL S. FOSTER, PAIGE LACY, A. BARRY KAY & MARC E. ROTHENBERG. (2008) Eosinophils: Biological Properties and Role in Health and Disease. Clinical & Experimental Allergy 38:5, pages 709-750.
Crossref
Crossref
Julia Eckardt-Michel, Markus Lorek, Diane Baxmann, Thomas Grunwald, Günther M. Keil & Gert Zimmer. (2008) The Fusion Protein of Respiratory Syncytial Virus Triggers p53-Dependent Apoptosis. Journal of Virology 82:7, pages 3236-3249.
Crossref
Crossref
W. Garrett Nichols, Angela J. Peck Campbell & Michael Boeckh. (2008) Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances. Clinical Microbiology Reviews 21:2, pages 274-290.
Crossref
Crossref
Peter L. Collins & Barney S. Graham. (2008) Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis. Journal of Virology 82:5, pages 2040-2055.
Crossref
Crossref
Changbao Liu, Nicole D Day, Patrick J Branigan, Lester L Gutshall, Robert T Sarisky & Alfred M Del Vecchio. (2007) Relationship between the loss of neutralizing antibody binding and fusion activity of the F protein of human respiratory syncytial virus. Virology Journal 4:1.
Crossref
Crossref
Robert W. Sidwell & Dale L. Barnard. (2006) Respiratory syncytial virus infections: Recent prospects for control. Antiviral Research 71:2-3, pages 379-390.
Crossref
Crossref
William F. Dall'Acqua, Peter A. Kiener & Herren Wu. (2006) Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn). Journal of Biological Chemistry 281:33, pages 23514-23524.
Crossref
Crossref
Shan-Ze Wang & Kevin S. Harrod. (2006) The immunobiology of respiratory syncytial virus infection. Clinical and Applied Immunology Reviews 6:1, pages 37-52.
Crossref
Crossref